{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:11:03Z","timestamp":1789603863204,"version":"build-2803163510"},"reference-count":97,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1006\/ebeh.2001.0281","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:46:35Z","timestamp":1032191195000},"page":"524-532","source":"Crossref","is-referenced-by-count":106,"title":["Herbal Medicines and Epilepsy: The Potential for Benefit and Adverse Effects"],"prefix":"10.1006","volume":"2","author":[{"given":"Marcello","family":"Spinella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/ebeh.2001.0281_RF1","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jama.280.18.1569","article-title":"Trends in alternative medicine use in the United States, 1990\u20131997: results of a follow-up national survey","volume":"280","author":"Eisenberg","year":"1998","journal-title":"JAMA"},{"key":"10.1006\/ebeh.2001.0281_RF2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/ebeh.2000.0031","article-title":"Alternative medicine use by patients with epilepsy","volume":"1","author":"Peebles","year":"2000","journal-title":"Epilepsy Behav"},{"key":"10.1006\/ebeh.2001.0281_RF3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1528-1157.1994.tb02442.x","article-title":"Use of alternative medicine by patients with epilepsy: a survey of 265 epileptic patients in a developing country","volume":"35","author":"Danesi","year":"1994","journal-title":"Epilepsia"},{"key":"10.1006\/ebeh.2001.0281_RF4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00001888-200103000-00012","article-title":"The growing need to teach about complementary and alternative medicine: questions and challenges","volume":"76","author":"Frenkel","year":"2001","journal-title":"Acad Med"},{"key":"10.1006\/ebeh.2001.0281_RF5","series-title":"Kava\u2014the Pacific elixir: the definitive guide to its ethnobotany, history, and chemistry","author":"Lebot","year":"1997"},{"key":"10.1006\/ebeh.2001.0281_RF6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00004714-200002000-00014","article-title":"Efficacy of kava extract for treating anxiety: systematic review and meta-analysis","volume":"20","author":"Pittler","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-2006-957502","article-title":"Influence of genuine kavapyrone enantiomers on the GABA-A binding site","volume":"64","author":"Boonen","year":"1998","journal-title":"Planta Med"},{"key":"10.1006\/ebeh.2001.0281_RF8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF02247480","article-title":"Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain","volume":"116","author":"Jussofie","year":"1994","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1006\/ebeh.2001.0281_RF9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0773.1992.tb00530.x","article-title":"Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain","volume":"712","author":"Davies","year":"1992","journal-title":"Pharmacol Toxicol"},{"key":"10.1006\/ebeh.2001.0281_RF10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/jps.2600771203","article-title":"Uptake into mouse brain of four compounds present in the psychoactive beverage kava","volume":"77","author":"Keledjian","year":"1988","journal-title":"J Pharm Sci"},{"key":"10.1006\/ebeh.2001.0281_RF11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0028-3908(95)00090-S","article-title":"(+\/\u2212)-Kavain inhibits veratridine-activated voltage-dependent Na(+)-channels in synaptosomes prepared from rat cerebral cortex","volume":"34","author":"Gleitz","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1006\/ebeh.2001.0281_RF12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0306-4522(97)00177-2","article-title":"Kava extract ingredients, (+)-methysticin and (+\/\u2212)-kavain inhibit voltage-operated Na(+)-channels in rat CA1 hippocampal neurons","volume":"81","author":"Magura","year":"1997","journal-title":"Neuroscience"},{"key":"10.1006\/ebeh.2001.0281_RF13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0924-977X(98)00008-X","article-title":"Effects of (+\/\u2212)-kavain on voltage-activated inward currents of dorsal root ganglion cells from neonatal rats","volume":"9","author":"Schirrmacher","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-2999(96)00550-X","article-title":"Anticonvulsive action of (+\/\u2212)-kavain estimated from its properties on stimulated synaptosomes and Na+ channel receptor sites","volume":"315","author":"Gleitz","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF15","first-page":"673","article-title":"[The action profile of d,l-kavain. Cerebral sites and sleep\u2013wakefulness-rhythm in animals]","volume":"41","author":"Holm","year":"1991","journal-title":"Arzneimittelforschung"},{"key":"10.1006\/ebeh.2001.0281_RF16","first-page":"505","article-title":"[Demonstration of the central effects of d,l-kawain with EEG brain mapping]","volume":"30;109","author":"Frey","year":"1991","journal-title":"Fortschr Med"},{"key":"10.1006\/ebeh.2001.0281_RF17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/09595239700186441","article-title":"Acute effects of kava, alone or in combination with alcohol, on subjective measures of impairment and intoxication and on cognitive performance","volume":"16","author":"Foo","year":"1997","journal-title":"Drug Alc Rev"},{"key":"10.1006\/ebeh.2001.0281_RF18","first-page":"251","article-title":"[Antagonistic action of natural 5,6-hydrogenated kava pyrones against strychnine poisoning and experimental local tetanus]","volume":"182","author":"Kretzschmar","year":"1969","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1006\/ebeh.2001.0281_RF19","first-page":"66","article-title":"Comparison of the central nervous system activity of the aqueous and lipid extract of kava (Piper methysticum)","volume":"301","author":"Jamieson","year":"1989","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1006\/ebeh.2001.0281_RF20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0028-3908(95)00163-8","article-title":"(+\/\u2212)-Kavain inhibits the veratridine- and KCl-induced increase in intracellular Ca2+ and glutamate-release of rat cerebrocortical synaptosomes","volume":"35","author":"Gleitz","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1006\/ebeh.2001.0281_RF21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1095-6433(98)10064-8","article-title":"The influence of (+\/\u2212)-kavain on population spikes and long-term potentiation in guinea pig hippocampal slices","volume":"120","author":"Langosch","year":"1998","journal-title":"Comp Biochem Physiol A"},{"key":"10.1006\/ebeh.2001.0281_RF22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1440-1681.1991.tb01493.x","article-title":"Development of tolerance to kava in mice","volume":"18","author":"Duffield","year":"1991","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1006\/ebeh.2001.0281_RF23","series-title":"The falling sickness: a history of epilepsy from the Greeks to the beginnings of modern neurology","author":"Temkin","year":"1971"},{"key":"10.1006\/ebeh.2001.0281_RF24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0091-3057(82)90264-7","article-title":"Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man","volume":"17","author":"Leathwood","year":"1982","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1006\/ebeh.2001.0281_RF25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2007-1014295","article-title":"The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study","volume":"27","author":"Schulz","year":"1994","journal-title":"Pharmacopsychiatry"},{"key":"10.1006\/ebeh.2001.0281_RF26","first-page":"473","article-title":"[Vigilance-decreasing effects of 2 plant-derived sedatives]","volume":"85","author":"Gerhard","year":"1996","journal-title":"Schweiz Rundsch Med Prax"},{"key":"10.1006\/ebeh.2001.0281_RF27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1211\/0022357991772772","article-title":"The scientific basis for the reputed activity of valerian","volume":"51","author":"Houghton","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2006-959538","article-title":"The amount of GABA present in aqueous extracts of valerian is sufficient to account for [3H]GABA release in synaptosomes","volume":"60","author":"Santos","year":"1994","journal-title":"Planta Med"},{"key":"10.1006\/ebeh.2001.0281_RF29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/s-2007-971218","article-title":"[Inhibition of gamma-aminobutyric acid catabolism by valerenic acid derivatives]","volume":"46","author":"Riedel","year":"1982","journal-title":"Planta Med"},{"key":"10.1006\/ebeh.2001.0281_RF30","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1023\/A:1022576405534","article-title":"Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release","volume":"24","author":"Ortiz","year":"1999","journal-title":"Neurochem Res"},{"key":"10.1006\/ebeh.2001.0281_RF31","first-page":"33","article-title":"[Biological activity of the sum of the valepotriates isolated from Valeriana alliariifolia]","volume":"50","author":"Dunaev","year":"1987","journal-title":"Farmakol Toksikol"},{"key":"10.1006\/ebeh.2001.0281_RF32","first-page":"44","article-title":"[Effect of valeprotriate on spontaneous motor activity in mice]","volume":"34","author":"H\u00f6lzl","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"10.1006\/ebeh.2001.0281_RF33","first-page":"638","article-title":"Characterisation of the central nervous depressant activity of a commercially available valerian root extract","volume":"43","author":"Leuschner","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"10.1006\/ebeh.2001.0281_RF34","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/0006-2952(90)90716-X","article-title":"Chrysin (5,7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties","volume":"40","author":"Medina","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0091-3057(94)90103-1","article-title":"Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea","volume":"47","author":"Wolfman","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1006\/ebeh.2001.0281_RF36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-8741(97)00042-1","article-title":"Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse","volume":"57","author":"Soulimani","year":"1997","journal-title":"J Ethnopharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1027303609517","article-title":"Overview\u2014flavonoids: a new family of benzodiazepine receptor ligands","volume":"22","author":"Medina","year":"1997","journal-title":"Neurochem Res"},{"key":"10.1006\/ebeh.2001.0281_RF38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2006-958058","article-title":"Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects","volume":"61","author":"Viola","year":"1995","journal-title":"Planta Med"},{"key":"10.1006\/ebeh.2001.0281_RF39","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0006-2952(00)00264-1","article-title":"Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla","volume":"59","author":"Avallone","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-8741(91)90119-X","article-title":"The pharmacology of psychoactive alkaloids from ephedra and catha","volume":"32","author":"Kalix","year":"1991","journal-title":"J Ethnopharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/j.1552-4604.1997.tb04769.x","article-title":"Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults","volume":"37","author":"White","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF42","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJM200012213432502","article-title":"Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids","volume":"343","author":"Haller","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1006\/ebeh.2001.0281_RF43","first-page":"621","article-title":"Epileptogenic properties of cocaine in humans","volume":"12","author":"Dhuna","year":"1991","journal-title":"Neurotoxicology"},{"key":"10.1006\/ebeh.2001.0281_RF44","first-page":"43","article-title":"Influence of parenterally administered amphetamine on the paroxysmal EEG activity in epileptics","volume":"33","author":"Rektor","year":"1984","journal-title":"Physiol Bohemoslov"},{"key":"10.1006\/ebeh.2001.0281_RF45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0091-3057(98)00044-6","article-title":"(\u2212)Ephedrine and caffeine mutually potentiate one another's amphetamine-like stimulus effects","volume":"61","author":"Young","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1006\/ebeh.2001.0281_RF46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0022-3956(84)90001-3","article-title":"Behavioral and molecular actions of caffeine: focus on adenosine","volume":"18","author":"Snyder","year":"1984","journal-title":"J Psychiatr Res"},{"key":"10.1006\/ebeh.2001.0281_RF47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0006-8993(87)90428-8","article-title":"Proconvulsant actions of theophylline and caffeine in the hippocampus: implications for the management of temporal lobe epilepsy","volume":"426","author":"Ault","year":"1987","journal-title":"Brain Res"},{"key":"10.1006\/ebeh.2001.0281_RF48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0006-8993(88)91421-7","article-title":"Comparative influence of calcium blocker and purinergic drugs on epileptiform bursting in rat hippocampal slices","volume":"441","author":"Frank","year":"1988","journal-title":"Brain Res"},{"key":"10.1006\/ebeh.2001.0281_RF49","first-page":"1412","article-title":"Modulation of epileptiform activity by adenosine A1 receptor-mediated mechanisms in the juvenile rat hippocampus","volume":"286","author":"Tancredi","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1006\/ebeh.2001.0281_RF50","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0091-3057(83)90062-X","article-title":"Caffeine modification of kindled amygdaloid seizures","volume":"19","author":"Albertson","year":"1983","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1006\/ebeh.2001.0281_RF51","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1176\/ajp.147.5.579","article-title":"Caffeine augmentation of ECT","volume":"147","author":"Coffey","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1006\/ebeh.2001.0281_RF52","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1080\/1028415X.1998.11747236","article-title":"Ginkgo biloba and memory: an overview","volume":"1","author":"Field","year":"1998","journal-title":"Nutr Neurosci"},{"key":"10.1006\/ebeh.2001.0281_RF53","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archneur.55.11.1409","article-title":"The efficacy of ginkgo biloba on cognitive function in Alzheimer disease","volume":"55","author":"Oken","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1006\/ebeh.2001.0281_RF54","first-page":"89","article-title":"The psychopharmacological effects of ginkgo biloba extract in normal healthy volunteers","volume":"4","author":"Subhan","year":"1984","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1006\/ebeh.2001.0281_RF55","first-page":"33","article-title":"[Comparative effects of Ginkgo biloba extracts on psychomotor performances and memory in healthy subjects]","volume":"46","author":"Warot","year":"1991","journal-title":"Therapie"},{"key":"10.1006\/ebeh.2001.0281_RF56","first-page":"304","article-title":"Changes in high-affinity choline uptake in the hippocampus of old rats after long-term administration of two nootropic drugs (tacrine and ginkgo biloba extract)","volume":"3","author":"Kristofikova","year":"1992","journal-title":"Dementia"},{"key":"10.1006\/ebeh.2001.0281_RF57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000106599","article-title":"In vitro effect of ginkgo biloba extract (EGb 761) on the activity of presynaptic cholinergic nerve terminals in rat hippocampus","volume":"8","author":"Kristofikova","year":"1997","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1006\/ebeh.2001.0281_RF58","first-page":"1491","article-title":"[Neuromediator binding to receptors in the rat brain: the effect of chronic administration of ginkgo biloba extract]","volume":"15","author":"Taylor","year":"1986","journal-title":"Presse Med"},{"key":"10.1006\/ebeh.2001.0281_RF59","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s002109900131","article-title":"Bilobalide, a constituent of ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus","volume":"360","author":"Weichel","year":"1999","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF60","first-page":"45","article-title":"Bilobalide, a constituent of ginkgo biloba L., potentiates drug-metabolizing enzyme activities in mice: possible mechanism for anticonvulsant activity against 4-O-methylpyridoxine-induced convulsions","volume":"96","author":"Sasaki","year":"1997","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF61","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7326\/0003-4819-134-4-200102200-00026","article-title":"Seizure associated with Ginkgo biloba?","volume":"134","author":"Gregory","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1006\/ebeh.2001.0281_RF62","first-page":"280","article-title":"Generalized convulsions after consuming a large amount of gingko nuts","volume":"42","author":"Miwa","year":"2001","journal-title":"Epilepsia"},{"key":"10.1006\/ebeh.2001.0281_RF63","first-page":"391","article-title":"The pharmacological effects of Ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine","volume":"34","author":"Itil","year":"1998","journal-title":"Psychopharmacol Bull"},{"key":"10.1006\/ebeh.2001.0281_RF64","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s002280050674","article-title":"The efficacy of ginseng: a systematic review of randomised clinical trials","volume":"55","author":"Vogler","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF65","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0006-2952(99)00212-9","article-title":"Ginseng pharmacology: multiple constituents and multiple actions","volume":"58","author":"Attele","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF66","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1507\/endocrj1954.26.661","article-title":"Stimulation of pituitary\u2013adrenocortical system by ginseng saponin","volume":"26","author":"Hiai","year":"1979","journal-title":"Endocrinol Jpn"},{"key":"10.1006\/ebeh.2001.0281_RF67","first-page":"932","article-title":"Preliminary study on antiamnestic mechanism of ginsenoside Rg1 and Rb1","volume":"103","author":"Zhang","year":"1990","journal-title":"Chin Med J (Engl)"},{"key":"10.1006\/ebeh.2001.0281_RF68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0303-7207(97)00160-3","article-title":"Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor","volume":"133","author":"Lee","year":"1997","journal-title":"Mol Cell Endocrinol"},{"key":"10.1006\/ebeh.2001.0281_RF69","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1528-1157.1984.tb03442.x","article-title":"Stress as a risk factor for seizures among adults with epilepsy","volume":"25","author":"Temkin","year":"1984","journal-title":"Epilepsia"},{"key":"10.1006\/ebeh.2001.0281_RF70","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1460-9568.1999.00495.x","article-title":"Episodic corticosterone treatment accelerates kindling epileptogenesis and triggers long-term changes in hippocampal CA1 cells, in the fully kindled state","volume":"11","author":"Karst","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1006\/ebeh.2001.0281_RF71","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0006-8993(93)90573-6","article-title":"Type I corticosteroid receptors modulate PTZ-induced convulsions of withdrawal seizure prone mice","volume":"626","author":"Roberts","year":"1993","journal-title":"Brain Res"},{"key":"10.1006\/ebeh.2001.0281_RF72","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.313.7052.253","article-title":"St John's wort for depression\u2014an overview and meta-analysis of randomised clinical trials","volume":"313","author":"Linde","year":"1996","journal-title":"Br Med J"},{"key":"10.1006\/ebeh.2001.0281_RF73","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00005053-199909000-00002","article-title":"St. John's wort for depression: a meta analysis of well-defined clinical trials","volume":"187","author":"Kim","year":"1999","journal-title":"J Nerv Ment Dis"},{"key":"10.1006\/ebeh.2001.0281_RF74","article-title":"St John's wort for depression","author":"Linde","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1006\/ebeh.2001.0281_RF75","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.285.15.1978","article-title":"Effectiveness of St John's wort in major depression: a randomized controlled trial","volume":"285","author":"Shelton","year":"2001","journal-title":"JAMA"},{"key":"10.1006\/ebeh.2001.0281_RF76","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004850-200015020-00001","article-title":"Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild\u2013moderate depression","volume":"2","author":"Schrader","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF77","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/S0010-440X(00)80019-X","article-title":"Potential treatment for subthreshold and mild depression: a comparison of St. John's wort extracts and fluoxetine","volume":"41","author":"Volz","year":"2000","journal-title":"Compr Psychiatry"},{"key":"10.1006\/ebeh.2001.0281_RF78","first-page":"289","article-title":"Comparison of equivalence between the St. John's wort extract LoHyp-57 and fluoxetine","volume":"49","author":"Harrer","year":"1999","journal-title":"Arzneimittelforschung"},{"key":"10.1006\/ebeh.2001.0281_RF79","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0149-2918(00)89010-4","article-title":"Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study","volume":"22","author":"Brenner","year":"2000","journal-title":"Clin Ther"},{"key":"10.1006\/ebeh.2001.0281_RF80","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1345\/aph.18026","article-title":"Neuropharmacology of St. John's Wort (Hypericum)","volume":"32","author":"Bennett","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1006\/ebeh.2001.0281_RF81","first-page":"1363","article-title":"Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1","volume":"290","author":"Singer","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1006\/ebeh.2001.0281_RF82","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/026988110101500109","article-title":"Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology","volume":"15","author":"Nathan","year":"2001","journal-title":"J Psychopharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF83","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-2007-979529","article-title":"In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract","volume":"30","author":"Cott","year":"1997","journal-title":"Pharmacopsychiatry"},{"key":"10.1006\/ebeh.2001.0281_RF84","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1073\/pnas.130155097","article-title":"St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor","volume":"97","author":"Moore","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/ebeh.2001.0281_RF85","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1345\/aph.18252","article-title":"Potential metabolic interaction between St. John's wort and theophylline","volume":"33","author":"Nebel","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1006\/ebeh.2001.0281_RF86","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0140-6736(99)05467-7","article-title":"Acute heart transplant rejection due to Saint John's wort","volume":"355","author":"Ruschitzka","year":"2000","journal-title":"Lancet"},{"key":"10.1006\/ebeh.2001.0281_RF87","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/cp.1999.v66.a101944","article-title":"Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)","volume":"66","author":"Johne","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1006\/ebeh.2001.0281_RF88","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0140-6736(05)73227-X","article-title":"Safety of St John's wort (Hypericum perforatum)","volume":"355","author":"Yue","year":"2000","journal-title":"Lancet"},{"key":"10.1006\/ebeh.2001.0281_RF89","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/ajhp\/57.7.625a","article-title":"Interaction between indinavir and St. John's wort reported","volume":"57","author":"Miller","year":"2000","journal-title":"Am J Health Syst Pharm"},{"key":"10.1006\/ebeh.2001.0281_RF90","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1067\/mcp.2000.111530","article-title":"Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers","volume":"68","author":"Burstein","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1006\/ebeh.2001.0281_RF91","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s004150050429","article-title":"Plant-induced seizures: reappearance of an old problem","volume":"246","author":"Burkhard","year":"1999","journal-title":"J Neurol"},{"key":"10.1006\/ebeh.2001.0281_RF92","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/07315724.2000.10718907","article-title":"The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms","volume":"19","author":"Bendich","year":"2000","journal-title":"J Am Coll Nutr"},{"key":"10.1006\/ebeh.2001.0281_RF93","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1001\/archinte.158.20.2200","article-title":"Herbal medicinals: selected clinical considerations focusing on known or potential drug\u2013herb interactions","volume":"158","author":"Miller","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1006\/ebeh.2001.0281_RF94","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(97)01467-2","article-title":"Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model","volume":"341","author":"Voskuyl","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF95","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(94)90387-5","article-title":"Essential fatty acid preparation (SR-3) raises the seizure threshold in rats","volume":"254","author":"Yehuda","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/ebeh.2001.0281_RF96","first-page":"S68","article-title":"Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations","volume":"53","author":"Alldredge","year":"1999","journal-title":"Neurology"},{"key":"10.1006\/ebeh.2001.0281_RF97","doi-asserted-by":"crossref","unstructured":"Dietary Supplement Health and Education Act of 1994, 1994; Pub L No. 103\u2013417.","DOI":"10.5594\/J09683"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505001902811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505001902811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T17:13:35Z","timestamp":1680542015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505001902811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S1525505001902811"],"URL":"https:\/\/doi.org\/10.1006\/ebeh.2001.0281","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}